Lincoln Pharmaceuticals Ltd. Capital Structure Analysis

From Year - To Year	Class Of Share	Authorized Capital (Crores)	Issued Capital (Crores)	Paid Up Shares (Nos)	Paid Up Face Value	Paid Up Capital (Crores)
2018 - 2019	Equity Share	20	20	2,00,00,000	10	20
2017 - 2018	Equity Share	20	20	2,00,00,000	10	20
2016 - 2017	Equity Share	20	20	2,00,00,000	10	20
2015 - 2016	Equity Share	20	16.31	1,63,10,800	10	16.31
2014 - 2015	Equity Share	20	16.31	1,63,10,800	10	16.31
2013 - 2014	Equity Share	20	16.31	1,63,10,800	10	16.31
2012 - 2013	Equity Share	20	16.31	1,63,10,800	10	16.31
2011 - 2012	Equity Share	20	16.31	1,63,10,800	10	16.31
2010 - 2011	Equity Share	20	16.31	1,63,10,800	10	16.31
2009 - 2010	Equity Share	12	11.31	1,13,10,800	10	11.31
2008 - 2009	Equity Share	10	7.61	76,10,800	10	7.61
2007 - 2008	Equity Share	9	7.61	3,80,54,000	2	7.61
2006 - 2007	Equity Share	9	7.61	3,80,54,000	2	7.61

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article